---
title: Testing oAuth
---

## Something Powerful

### Tell The Reader More

The headline and subheader tells us what you're [offering](https://www.robertpainslie.com/oauth#), and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

- Bullets are great
- For spelling out [benefits](https://www.robertpainslie.com/oauth#) and
- Turning visitors into leads.

[Authorize the App on HubSpot](https://app.hubspot.com/oauth/authorize?client_id=b839ea06-f730-4ebd-88e8-c2c6ba8ce4ae&scope=contacts%20automation%20content%20reports%20social%20timeline%20forms%20files%20hubdb&redirect_uri=https://www.robertpainslie.com/oauth)

Add a short bio for this team member. Try to keep each of these consistent in scope and format. Most importantly, remember to use your company's voice for this copy. This is the place where folks come to find out who you are as an organization and what kind of people they might be interacting with if they choose to work with you.

 {} all: {has_more=false, offset=0, total=0, results=[{company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}]} ticket id: id: {} query: {has_more=false, offset=0, total=0, results=[{company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}]} 204631   
 Associations:  
 {has_more=false, offset=0, total=0, results=[{company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}, {company_name=NOF CORPORATION, company_website=nof.co.jp, profile=NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators., display_logo=https://8696823.fs1.hubspotusercontent-na1.net/hubfs/8696823/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/8abf47ad-fcc3-43ad-a211-123819a75fa1-2-5668375logo-03_%E8%8B%B1%E6%96%87%E3%83%9E%E3%83%BC%E3%82%AFNOF.jpg, id=19400833187, sponsorship_package=Gold Sponsor, project_name=null}]}

- Ticket ID: {{item.hs_ticket_id}}
- Ticket Subject: {{item.subject}}
- Ticket Message: {{item.content}}
- Ticket Opened Date: {{item.createdate}}

Connect with us   [![](https://cdn2.hubspot.net/hub/344164/file-708426311-png/Landing_Page_Assets/youtube.png)](https://www.youtube.com/user/ColtTechnology)  [![](https://cdn2.hubspot.net/hub/344164/file-708426316-png/Landing_Page_Assets/twitter.png?width=25&height=25&name=twitter.png)](http://www.twitter.com/coltbenelux)  [![](https://cdn2.hubspot.net/hub/344164/file-711535195-png/Landing_Page_Assets/linkedIn.png?width=25&height=25&name=linkedIn.png)](http://www.linkedin.com/company/colt-technology-services)  [![](https://cdn2.hubspot.net/hub/344164/file-708426306-png/Landing_Page_Assets/blog.png?width=25&height=25&name=blog.png)](http://www.colt.net/be/en/blogs/index.htm)  [![](https://cdn2.hubspot.net/hub/344164/file-711535200-png/Landing_Page_Assets/e-icon.png?width=25&height=25&name=e-icon.png)](http://engage.colt.net/be/)

Connect with us   [![](https://cdn2.hubspot.net/hub/344164/file-708426311-png/Landing_Page_Assets/youtube.png)](https://www.youtube.com/user/ColtTechnology)  [![](https://cdn2.hubspot.net/hub/344164/file-708426316-png/Landing_Page_Assets/twitter.png?width=25&height=25&name=twitter.png)](http://www.twitter.com/coltbenelux)  [![](https://cdn2.hubspot.net/hub/344164/file-711535195-png/Landing_Page_Assets/linkedIn.png?width=25&height=25&name=linkedIn.png)](http://www.linkedin.com/company/colt-technology-services)  [![](https://cdn2.hubspot.net/hub/344164/file-708426306-png/Landing_Page_Assets/blog.png?width=25&height=25&name=blog.png)](http://www.colt.net/be/en/blogs/index.htm)  [![](https://cdn2.hubspot.net/hub/344164/file-711535200-png/Landing_Page_Assets/e-icon.png?width=25&height=25&name=e-icon.png)](http://engage.colt.net/be/)